We are live on ! Find out more
BGIM

Brandywine Global Investment Management Portfolio holdings

AUM $14.9B
1-Year Est. Return 20.41%
This Fund
S&P 500
This Quarter Est. Return
+15.06%
1 Year Est. Return
+20.41%
3 Year Est. Return
+61.22%
5 Year Est. Return
+111.48%
10 Year Est. Return
+294.16%
AUM
$12.8B
AUM Growth
+$2.07B
Cap. Flow
+$597M
Cap. Flow %
4.66%
Top 10 Hldgs %
17.62%
Holding
803
New
70
Increased
336
Reduced
263
Closed
84

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$84.8M
2
COP icon
ConocoPhillips
COP
+$83M
3
T icon
AT&T
T
+$67M
4
KR icon
Kroger
KR
+$47.7M
5
MRNA icon
Moderna
MRNA
+$40.8M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$157M
2
LMT icon
Lockheed Martin
LMT
+$71.8M
3
DE icon
Deere & Co
DE
+$70.6M
4
ZBH icon
Zimmer Biomet
ZBH
+$41.7M
5
DHI icon
D.R. Horton
DHI
+$39.7M

Sector Composition

Rank Sector Weight
1 Financials 24.28%
2 Healthcare 18.31%
3 Consumer Discretionary 9.71%
4 Energy 9.42%
5 Technology 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
51
Gilead Sciences
GILD
$169B
$65M 0.51%
757,404
-52,590
-6% -$4.16M
AFL icon
52
Aflac
AFL
$60.5B
$63.6M 0.5%
884,545
+221,973
+34% +$14.9M
JNJ icon
53
Johnson & Johnson
JNJ
$627B
$63.4M 0.5%
358,861
+64,239
+22% +$11.1M
EOG icon
54
EOG Resources
EOG
$74.6B
$61.8M 0.48%
477,141
-34,889
-7% -$4.64M
PHM icon
55
Pultegroup
PHM
$24.6B
$61.3M 0.48%
1,347,331
+134,065
+11% +$5.65M
SHEL icon
56
Shell
SHEL
$248B
$60.3M 0.47%
1,058,767
+59,253
+6% +$3.27M
HZNP
57
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$60.2M 0.47%
528,993
-144,930
-22% -$12M
GPN icon
58
Global Payments
GPN
$22.4B
$59.9M 0.47%
603,041
+22,989
+4% +$2.4M
FE icon
59
FirstEnergy
FE
$27.1B
$59.5M 0.46%
1,419,278
+239,816
+20% +$9.38M
DUK icon
60
Duke Energy
DUK
$96.1B
$59.1M 0.46%
573,687
+97,970
+21% +$9.4M
TER icon
61
Teradyne
TER
$63.6B
$56.5M 0.44%
647,145
-130,105
-17% -$11.1M
DAL icon
62
Delta Air Lines
DAL
$58.8B
$56M 0.44%
1,704,265
+197,778
+13% +$6.55M
SCCO icon
63
Southern Copper
SCCO
$164B
$55.9M 0.44%
995,581
+371,094
+59% +$18.7M
JAZZ icon
64
Jazz Pharmaceuticals
JAZZ
$16.3B
$54.4M 0.42%
341,548
+12,437
+4% +$1.82M
DD icon
65
DuPont de Nemours
DD
$19.3B
$54.2M 0.42%
629,564
-235,879
-27% -$18.8M
TGT icon
66
Target
TGT
$69.3B
$54M 0.42%
362,406
+177,473
+96% +$27.8M
MO icon
67
Altria Group
MO
$108B
$53.7M 0.42%
1,175,367
-83,895
-7% -$3.8M
FLG
68
Flagstar Bank National Association
FLG
$5.92B
$52.5M 0.41%
2,034,108
+735,480
+57% +$19.7M
KLAC icon
69
KLA
KLAC
$271B
$52M 0.41%
1,380,430
+442,370
+47% +$15.4M
MDT icon
70
Medtronic
MDT
$115B
$50.7M 0.4%
651,868
+151,786
+30% +$12.3M
LH icon
71
Labcorp
LH
$25.9B
$50M 0.39%
247,007
+69,639
+39% +$13.6M
PXD
72
DELISTED
Pioneer Natural Resource Co.
PXD
$49.9M 0.39%
218,590
+86,750
+66% +$21.1M
GSK icon
73
GSK
GSK
$100B
$49.9M 0.39%
1,419,870
+161,017
+13% +$5.36M
MCK icon
74
McKesson
MCK
$104B
$49.3M 0.39%
131,512
-9,537
-7% -$3.56M
VNT icon
75
Vontier
VNT
$4.52B
$48.6M 0.38%
2,513,251
+193,169
+8% +$3.62M

Similar funds

Brandywine Global Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Brandywine Global Investment Management held 803 positions worth $12.8B, up 19% from $10.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Brandywine Global Investment Management deployed $597M of net new capital in Q4 2022, opening 70 new positions and adding to 336 existing holdings. Its largest new stake was Moderna: 249,251 shares worth $44.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Zimmer Biomet, an estimated $41.7M trimmed.

  • Brandywine Global Investment Management's largest Q4 2022 buy was Moderna: 249,251 shares worth $44.8M.
  • Brandywine Global Investment Management added most to Applied Materials in Q4 2022, an estimated $84.8M increase.
  • Brandywine Global Investment Management's biggest Q4 2022 reduction was Zimmer Biomet, cutting an estimated $41.7M.
  • Brandywine Global Investment Management fully exited Oracle in Q4 2022, selling an estimated $157M.
  • Brandywine Global Investment Management's ten largest holdings make up 18% of its $12.8B portfolio in Q4 2022.
  • Brandywine Global Investment Management opened 70 new positions and closed 84 in Q4 2022.
  • Brandywine Global Investment Management's portfolio value rose 19% quarter-over-quarter to $12.8B.

Based on Brandywine Global Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.